載入...
Diffuse pulmonary lymphangiomatosis treated with bevacizumab
Diffuse pulmonary lymphangiomatosis (DPL) is a rare disease caused by uncontrolled lymphatic vessel proliferation resulting in respiratory dysfunction. Lymphatic vessel growth is influenced by vascular endothelial growth factor (VEGF). It has been shown that bevacizumab, a monoclonal antibody to VEG...
Na minha lista:
| 發表在: | Respirol Case Rep |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6260917/ https://ncbi.nlm.nih.gov/pubmed/30510764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.384 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|